Cardiac disease in mucopolysaccharidosis type I attributed to catecholaminergic and hemodynamic deficiencies

Am J Physiol Heart Circ Physiol. 2011 Jan;300(1):H356-65. doi: 10.1152/ajpheart.00774.2010. Epub 2010 Nov 12.

Abstract

Cardiac dysfunction is a common cause of death among pediatric patients with mutations in the lysosomal hydrolase α-l-iduronidase (IDUA) gene, which causes mucopolysaccharidosis type I (MPS-I). The purpose of this study was to analyze adrenergic regulation of cardiac hemodynamic function in MPS-I. An analysis of murine heart function was performed using conductance micromanometry to assess in vivo cardiac hemodynamics. Although MPS-I (IDUA(-/-)) mice were able to maintain normal cardiac output and ejection fraction at baseline, this cohort had significantly compromised systolic and diastolic function compared with IDUA(+/-) control mice. During dobutamine infusion MPS-I mice did not significantly increase cardiac output from baseline, indicative of blunted cardiac reserve. Autonomic tone, measured functionally by β-blockade, indicated that MPS-I mice required catecholaminergic stimulation to maintain baseline hemodynamics. Survival analysis showed mortality only among MPS-I mice. Linear regression analysis revealed that heightened end-systolic volume in the resting heart is significantly correlated with susceptibility to mortality in MPS-I hearts. This study reveals that cardiac remodeling in the pathology of MPS-I involves heightened adrenergic tone at the expense of cardiac reserve with cardiac decompensation predicted on the basis of increased baseline systolic volumes.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-1 Receptor Agonists / pharmacology
  • Animals
  • Anthracenes
  • Blotting, Western
  • Dobutamine / pharmacology
  • Heart / drug effects
  • Heart / physiopathology*
  • Heart Diseases / metabolism*
  • Heart Diseases / physiopathology*
  • Hemodynamics
  • Linear Models
  • Mice
  • Mice, Knockout
  • Mucopolysaccharidosis I / metabolism*
  • Mucopolysaccharidosis I / physiopathology*
  • Myocardium / metabolism*
  • Phosphorylation
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • Adrenergic beta-1 Receptor Agonists
  • AnOV compound
  • Anthracenes
  • Dobutamine